Recommendations

ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
97
134. Tan KH, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic
determinants of coronary angioplasty success and complications:
current experience. J Am Coll Cardiol 1995;25:855-65.
135. Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and
validation of simplified predictive index for major complications
in contemporary percutaneous transluminal coronary angioplasty
practice: the Registry Committee of the Society for Cardiac
Angiography and Interventions. J Am Coll Cardiol 1995;26:931-8.
136. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels
of C-reactive protein predict early complications and late
restenosis after coronary angioplasty. J Am Coll Cardiol
1999;34:1512-21.
137. Mueller C, Neumann FJ, Perruchoud AP, Buettner HJ. Renal
function and long term mortality after unstable angina/non-ST
segment elevation myocardial infarction treated very early and
predominantly with percutaneous coronary intervention. Heart
2004;90:902-7.
138. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal
dysfunction with cardiac angiography. Ann Intern Med
1986;104:501-4.
139. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic
importance of acute renal failure after percutaneous coronary
intervention. Circulation 2002;105:2259-64.
140. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications
of further renal function deterioration within 48 h of interventional
coronary procedures in patients with pre-existent chronic
renal insufficiency. J Am Coll Cardiol 2000;36:1542-8.
141. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency
on clinical outcomes in patients undergoing percutaneous
coronary interventions. J Am Coll Cardiol 2002;39:1113-9.
142. Naidu SS, Selzer F, Jacobs A, et al. Renal insufficiency is an independent
predictor of mortality after percutaneous coronary intervention.
Am J Cardiol 2003;92:1160-4.
143. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency
in patients undergoing primary angioplasty for acute
myocardial infarction. Circulation 2003;108:2769-75.
144. Ellis SG, Myler RK, King SB, III, et al. Causes and correlates of
death after unsupported coronary angioplasty: implications for
use of angioplasty and advanced support techniques in high-risk
settings. Am J Cardiol 1991;68:1447-51.
145. Block P, Peterson E, Krone R, et al. Identification of variables
needed to risk adjust outcome of coronary interventions: evidence-based
guidelines for efficient data collection. J Am Coll
Cardiol 1998;32:275-82.
146. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline
update for coronary artery bypass graft surgery: summary
article. A report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (Committee
to Update the 1999 Guidelines for Coronary Artery Bypass Graft
Surgery). J Am Coll Cardiol 2004;44:1146-310.
147. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous
treatment of unprotected left main coronary stenoses: initial
results from a multicenter registry analysis 1994-1996.
Circulation 1997;96:3867-72.
148. Silvestri M, Barragan P, Sainsous J, et al. Unprotected left main
coronary artery stenting: immediate and medium-term outcomes
of 140 elective procedures. J Am Coll Cardiol 2000;35:1543-50.
149. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J.
Unprotected left main coronary artery stenting: correlates of
midterm survival and impact of patient selection. J Am Coll
Cardiol 2001;37:832-8.
150. Park SJ, Hong MK, Lee CW, et al. Elective stenting of unprotect-
ed left main coronary artery stenosis: effect of debulking before
stenting and intravascular ultrasound guidance. J Am Coll Cardiol
2001;38:1054-60.
151. Kelley MP, Klugherz BD, Hashemi SM, et al. One-year clinical
outcomes of protected and unprotected left main coronary artery
stenting. Eur Heart J 2003;24:1554-9.
152. Park SJ, Park SW, Hong MK, et al. Long-term (three-year) outcomes
after stenting of unprotected left main coronary artery
stenosis in patients with normal left ventricular function. Am J
Cardiol 2003;91:12-6.
153. Tan WA, Tamai H, Park SJ, et al. Long-term clinical outcomes
after unprotected left main trunk percutaneous revascularization
in 279 patients. Circulation 2001;104:1609-14.
154. Takagi T, Stankovic G, Finci L, et al. Results and long-term predictors
of adverse clinical events after elective percutaneous interventions
on unprotected left main coronary artery. Circulation
2002;106:698-702.
155. Sakai K, Nakagawa Y, Kimura T, et al. Primary angioplasty of
unprotected left main coronary artery for acute anterolateral
myocardial infarction. J Invasive Cardiol 2004;16:621-5.
156. de Lezo JS, Medina A, Pan M, et al. Rapamycin-eluting stents for
the treatment of unprotected left main coronary disease. Am Heart
J 2004;148:481-5.
157. Arampatzis CA, Lemos PA, Hoye A, et al. Elective sirolimuseluting
stent implantation for left main coronary artery disease:
six-month angiographic follow-up and 1-year clinical outcome.
Catheter Cardiovasc Interv 2004;62:292-6.
158. Agostoni P, Valgimigli M, Van Mieghem CA, et al. Comparison
of early outcome of percutaneous coronary intervention for
unprotected left main coronary artery disease in the drug-eluting
stent era with versus without intravascular ultrasonic guidance.
Am J Cardiol 2005;95:644-7.
159. Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term
results of drug-eluting stent implantation in unprotected left main.
Circulation 2005;111:791-5.
160. Park SJ, Kim YH, Lee BK, et al. Sirolimus-eluting stent implantation
for unprotected left main coronary artery stenosis: comparison
with bare metal stent implantation. J Am Coll Cardiol
2005;45:351-6.
161. Valgimigli M, Van Mieghem CA, Ong AT, et al. Short- and longterm
clinical outcome after drug-eluting stent implantation for the
percutaneous treatment of left main coronary artery disease:
insights from the Rapamycin-Eluting and Taxus Stent Evaluated
At Rotterdam Cardiology Hospital registries (RESEARCH and T-
SEARCH). Circulation 2005;111:1383-9.
162. Sadeghi HM, O’Neill WW, Grines CL. Percutaneous intervention
of unprotected left main coronary artery. J Interv Cardiol
2003;16:281-8.
163. Bergelson BA, Jacobs AK, Cupples LA, et al. Prediction of risk
for hemodynamic compromise during percutaneous transluminal
coronary angioplasty. Am J Cardiol 1992;70:1540-5.
164. Califf RM, Phillips HR3, Hindman MC, et al. Prognostic value of a
coronary artery jeopardy score. J Am Coll Cardiol 1985;5:1055-63.
165. Holmes DRJ, Holubkov R, Vlietstra RE, et al. Comparison of complications
during percutaneous transluminal coronary angioplasty
from 1977 to 1981 and from 1985 to 1986: the National Heart,
Lung, and Blood Institute Percutaneous Transluminal Coronary
Angioplasty Registry. J Am Coll Cardiol 1988;12:1149-55.
166. Sinclair IN, McCabe CH, Sipperly ME, Baim DS. Predictors,
therapeutic options and long-term outcome of abrupt reclosure.
Am J Cardiol 1988;61:61G-6G.
167. Anderson RD, Ohman EM, Holmes DR, Jr, et al. Prognostic value